Pancreatic cancers require autophagy for tumor growth
Harvard University · Dana-Farber Cancer Institute · +8 more institutions
Abstract
Macroautophagy (autophagy) is a regulated catabolic pathway to degrade cellular organelles and macromolecules. The role of autophagy in cancer is complex and may differ depending on tumor type or context. Here we show that pancreatic cancers have a distinct dependence on autophagy. Pancreatic cancer primary tumors and cell lines show elevated autophagy under basal conditions. Genetic or pharmacologic inhibition of autophagy leads to increased reactive oxygen species, elevated DNA damage, and a metabolic defect leading to decreased mitochondrial oxidative phosphorylation. Together, these ultimately result in significant growth suppression of pancreatic cancer cells in vitro. Most importantly, inhibition of…
Citation impact
- FWCI
- —
- Percentile
- —
- References
- 56
Authors
17- SYShenghong YangCorresponding
Harvard University, Dana-Farber Cancer Institute
- XWXiaoxu Wang
Harvard University, Dana-Farber Cancer Institute
- GCGianmarco Contino
Harvard University, University of Milan, Massachusetts General Hospital, Center for Cancer Research, European Institute of Oncology
- MLMarc Liesa
Boston University
- ESErgün Sahin
Harvard University, Dana-Farber Cancer Institute
Topics & keywords
- Autophagy
- Pancreatic cancer
- Biology
- Cancer research
- Context (archaeology)
- Cancer cell
- Cancer
- Apoptosis
- Good health and well-being